Immunotherapy for Lung Cancer
Physician-evaluated NK cell immunotherapy for patients diagnosed with Lung Cancer - including advanced and recurrent cases.
Lung Cancer: Overview
Lung cancer is often treated with surgery, chemotherapy, radiation, targeted therapy, or immune checkpoint inhibitors. However, many patients continue looking for additional options — especially when the disease is advanced, recurrent, or when quality of life becomes a major concern.
NK Cell Immunotherapy offers a cellular approach designed to support the immune system's natural ability to identify and respond to abnormal cells.
"In lung cancer, the immune environment is particularly challenging. Strengthening the body's own defenses is one of the most meaningful steps a patient can explore."
Giostar Medical Team
Why early action is Critical
Lung cancer is one of the most urgent cancer diagnoses - often detected at advanced stages.
Cancer death ranking
1 in 8
leading cause of cancer death in the United States — for both men and women.
new cases - 2026 est.
229,410
new lung cancer cases estimated in the U.S. in 2026. (American Cancer Society)
Advanced disease may affect
Breating capacity
Energy and stamina
Mobility and independence
Overall quality of life
When lung cancer progresses, it can affect breathing, energy, mobility, and independence. Delaying action may limit available options and allow the disease to become harder to manage.
Why Consider Cellular Immunotherapy?
Natural Killer cells are part of the innate immune system and play an important role in detecting and eliminating abnormal or stressed cells. For lung cancer patients, this matters because lung tumors can create an immune-suppressive environment that makes it harder for the body to recognize and respond effectively.
Nk cell mechanism
How Natural Killer Cells Target Cancer
Tumor Cell
Cancer cells evade normal immune detection
NK Recognition
NK cells detect "missing self" signals on abnormal cells
Cytotoxic Release
NK cells deploy perforin and granzymes
Cell Elimination
Tumor cell undergoes targeted aproptosis
In the clinical program, NK cells are collected from the patient, expanded in a controlled laboratory setting, and reinfused under physician oversight — supporting the body's own immune targeting capacity.
NK Cell Therapy is designed to:
Support immune surveillance
Help the immune system recognize abnormal cells
Provide a systemic, whole-body immune approach
Complement a broader treatment strategy when medically appropriate
Are You a Candidate?
NK Cell Immunotherapy may be considered for patients who:
Have been diagnosed with breast cancer (any stage, subject to evaluation)
Are exploring complementary or alternative treatment options
Have experienced recurrence or progression
Are seeking a less invasive, immune-based approach
Want to support their immune system during or after treatment
Every case is individually reviewed by our medical team to determine eligibility and design a personalized protocol.
Not all breast cancer patients qualify for our program. Eligibility is determined individually through physician-led medical review. This page provides general educational context — not medical advice or a determination of suitability.
A More Comprehensive Approach
At GIOSTAR, treatment goes beyond cellular therapy. Your program may include:
Enhance immune surveillance
Support identification and elimination of abnormal cells
Complement conventional treatments
Provide a systemic, whole-body approach
Clinical process
How the Process Works
Medical Evaluation
Your diagnosis, medical history, and treatment goals are reviewed by our physicians.
Immune Profiling & Blood Collection
A blood sample is collected to isolate immune cells and assess baseline function.
NK Cell Expansion
NK cells are activated and expanded in our specialized laboratory.
Controlled Reinfusion
Expanded NK cells are administered intravenously under clinical protocols.
Monitoring & Follow-Up
Progress is tracked through advanced laboratory testing and physician follow-up.
Next Step: Medical Review
If you or a family member has been diagnosed with breast cancer and is exploring additional options, the first step is to submit your case for physician review. Our team will assess your specific situation and respond with an eligibility determination.